MIRA Pharmaceuticals, Inc. MIRA

Morgan Stanley Initiates Coverage of NVR at Underweight

Demand Fears Undercut Sugar Prices

Can Shiba Inu Reach $1 In the Next 12 Months?

Micron's Next Big AI Opportunity Could Have 2 Legs

Cotton Starting Off Thursday with Losses

Hogs Look to Thursday Trade

Wheat Pushing Higher on Thursday

Corn Starting Thursday on the Steadier Side

Cattle Look to Thursday After Wednesday Rally

3 High-Yield Financial Stocks to Buy in October

Sam Altman's OpenAI Paused AI Training for the Second Time in 3 Months After Agents Escaped a Secure Sandbox and Accessed U.S. Government Websites. Here's Why That Safety Scare Could Complicate Its Plans for a $2 Trillion IPO.

Warren Buffett's Successor Has Billions Invested in These 2 Tech Stocks. Here's the Better Buy.

MRT-8102 Delivers Broad Inflammation Reductions In Monte Rosa Trial

Here's What a $10,000 Investment in SpaceX Stock Could Be Worth in 2035 (Hint: It's a Lot)

Why Synopsys Stock Soared on Thursday

Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?

Stocks Climb on a Strong Forecast from Micron

Dollar Rallies on Higher T-note Yields and US Economic Strength

Stocks Erase Gains as Inflation Risks Push Bond Yields Higher

Argus Research Upgrades Regeneron Pharmaceuticals to Buy from Hold